Clinical Trial Update: Study of High-Dose Intravenous (IV) Vitamin C Treatment in Patients With Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 study evaluating high-dose intravenous vitamin C in patients with solid tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Vitamin C (ascorbic acid)

Snippet

Sponsor: Midwestern Regional Medical Center | Conditions: Cancer | Phase 1 | Status: COMPLETED